CENTESSA

Welcome to the Brand page for “CENTESSA”, which is offered here for Downloadable and recorded software for drug delivery devices; downloadable and recorded software for administering and controlling drug delivery; downloadable and recorded software for use in medical and drug decision support; downloadable and recorded software for use in the acquisition, storage, sharing and analysis of medical data;pharmaceutical products, preparations, and medicines for the treatment or prevention of hemophilia, tumors, hypertension, narcolepsy, inflammatory diseases or disorders, fibrotic diseases or disorders, autoimmune diseases or disorders, respiratory diseases or disorders, cardiovascular diseases or disorders, central nervous system diseases or disorders, immune system diseases or disorders, cancer, intractable diseases of liver, lung, and heart, and endocrinology diseases or disorders;medical services; providing medical information and pharmaceutical information services, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consultation and counseling services; treatments for orphan diseases of the kidney, including adpkd (autosomal dominant polycystic kidney disease); medical services, providing medical therapies for hemophilia; medical services, administration of pharmaceutical treatments for pulmonary arterial hypertension, oncological and autoimmune diseases; medical services, providing medical treatments for narcolepsy; medical services, providing medical treatments for skin disorders;medical devices, drug delivery devices and devices for delivering nasal spray treatments;scientific and technological services and research in the medical and pharmaceutical field, pharmaceutical product development; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; medical laboratories; scientific and technological services and research and design relating thereto in the field of drug discovery; development of computer hardware and software;.

Its status is currently believed to be active. Its class is unavailable. “CENTESSA” is believed to be currently owned by “Centessa Pharmaceuticals plc”.